Mal-Dap(Boc)-Val-Ala-PAB-PNP

Nombre químico: N-alpha-Maleimido-N-beta-t-butyloxycarbonyl-L-2,3-diaminopropionyl-valyl-alanyl-(4-aminobenzyl)-(4-nitrophenyl)-carbonate // Sinónimos: tert-butyl(S)-2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-((S)-3-methyl-1-((S)-1-(4-(((4-nitrophenoxy)carbonyloxy)methyl)phenylamino)-1-oxopropan-2-ylamino)-1-oxobutan-2-ylamino)-3-oxopropylcarbama te

  • Nº Artículo:ADC1080
  • Fórmula:C34H40N6O12
  • Storage temperature:-20°C
  • Masa molecular:721,71 g/mol

from 500,00 €

Grouped product items
Cantidad Unidad de venta Precio Unidad de almacenamiento de stock (SKU) Disponibilidad
100 mg
500,00 €
ADC1080.0100
11-20 días laborables
250 mg
1.000,00 €
ADC1080.0250
11-20 días laborables
500 mg
1.800,00 €
ADC1080.0500
11-20 días laborables
Hoja de seguridad
description

Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ACD payload will be release in the cell, only. MAL-Dap(Boc) building blocks are ideal tools for persistent conjugation with thiol groups: After removal of the Boc protecting group and conjugation with the mercaptane function, the free methylamino side chain will open the maleimide ring under aqueous conditions. While the conjugation reaction between thiol and cyclic maleimide is reversible, it turns completely stable in the open ring structure. This becomes particularly important in the formation of conjugates with high value components.

Please note the patent WO2013173337 for use of this compound in commercial applications, particular for antibody-drug conjugates.


references

Laurent Ducry (ed.), Antibody-Drug Conjugates, Methods in Molecular Biology, vol. 1045, DOI 10.1007/978-1-62703-541-5_5, # Springer Science+Business Media, LLC 2013.

Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates; R.P. Lyon, J.R. Setter, T.D. Bovee, S.O. Doronia, J.H. Hunter, M.E. Anderson, C.L. Balasubramanian, S.M. Duniho, C.I. Leiske, F. Li, P.D. Senter; Nature Biotechnology 2014; 32(10): 1059-1062. DOI:10.1038/nbt.2968.

WO2013173337


* Disclaimer
We refer to our general terms and conditions.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.

¿Necesita más información sobre este producto?

ponerse en contacto

Contacto rápido

Por favor envíeme más información sobre

¡Otros productos que también podrían interesarle!